Back

XUND

Company Overview

XUND is a digital health company founded in 2018 that aims to improve healthcare by digitizing patient interactions and translating data into actionable insights. The company is headquartered in Vienna, Austria, with additional offices in Budapest and London. XUND has developed an AI-powered Patient Interaction Suite that enables healthcare companies to provide digital front-door solutions for patients.

Products Overview

XUND’s core product is the Patient Interaction Suite, which consists of several modular components:

  1. Symptom Check - Allows patients to check their symptoms and get guidance on potential causes and next steps. It covers 520+ conditions and 21,000+ symptom variants.

  2. Illness Check - Enables patients to assess the likelihood of specific conditions and understand the rationale.

  3. Health Check - Provides asymptomatic patients with 360° risk assessments based on lifestyle, medication, and medical history.

  4. Patient Monitoring - Allows for continuous digital monitoring of patients’ wellbeing over time.

The suite also includes add-on services like a Client Hub for analytics, Medical Content, a Medical Library, Healthcare Provider search, Data Insights, and Ecosystem Management tools.

XUND’s solutions are available via API, SDKs, or as a white-label Web App for easy integration into existing digital health platforms.

Founding Team

XUND was founded in 2018 by:

  • Tamás Petrovics - Co-Founder & CEO
  • Lukas Seper - Co-Founder & Strategic Partnerships
  • Dr. Zoltán Tarabó - Co-Founder & Medical Affairs Director

Problem and Market Fit

XUND aims to address several key challenges in healthcare:

  1. Improving patient access to reliable medical information and guidance
  2. Reducing unnecessary doctor visits and healthcare costs
  3. Enabling digital-first patient journeys and remote monitoring
  4. Helping healthcare providers collect structured patient data
  5. Assisting with triage and navigation to appropriate care

The company’s AI-powered solutions fit into the rapidly growing digital health market, which is projected to reach $256.30 billion by 2027.

Business Model

XUND operates on a B2B model, providing its Patient Interaction Suite to healthcare companies, insurers, pharmacies, and digital health platforms. The company uses a modular pricing approach, allowing clients to select and pay for only the components they need. XUND’s solutions can be integrated via API or used as white-label products.

Funding and Runway

XUND has raised a total of €10 million across 4 funding rounds since 2020. Key investors include:

  • MMC Ventures
  • MassMutual Ventures
  • RoX Health (ROCHE Group)
  • LANA Ventures
  • Peak Pride
  • TBA (Tyrolean Business Angel)
  • Schütz Family Office
  • Thieme Group

The company has also received over €1 million in grants for research activities.

Competitive Landscape

While specific competitors are not named, XUND operates in the competitive digital health and symptom checker market. The company differentiates itself through:

  1. MDR-certified (Class IIa) medical devices
  2. AI-driven medical knowledge base
  3. Modular and customizable solutions
  4. Focus on medical accuracy and quality
  5. Partnerships with established healthcare and insurance companies

Customers

XUND has several notable customers and partners, including:

  • Thieme Group
  • Generali
  • Wiener Städtische Versicherung
  • Doktor24
  • Zencey
  • Fitpuli
  • Semmelweis University

Relevant News

  • November 2023: Partnered with Fitpuli to enhance workplace health solutions
  • October 2023: Collaborated with Semmelweis University to research XUND’s medical assistant in emergency departments
  • 2023: Partnered with Zencey to integrate XUND’s Medical API into their mobile healthcare app
  • 2022: Generali Health Solutions GmbH integrated XUND’s technology into their Mobile Health app
  • July 2022: DoctorBox integrated XUND’s Medical API into their super-app

XUND continues to expand its partnerships and integrations across the digital health ecosystem, with a focus on improving patient journeys and healthcare outcomes through AI-powered solutions.

Classification: AI Tier 2

  1. Core AI: Create fundamental AI technologies/base models
  2. AI-Enabled: Core offerings rely on recent AI advances
  3. AI Adopters: Use AI to enhance existing products/services
  4. Non-AI: No AI in products/services

XUND’s business relies heavily on AI to provide advanced health assessments and monitoring, making it dependent on recent AI breakthroughs.